Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
The identification of gene expression profiles associated with progression of
human diabetic neuropathy.
Hur J, Sullivan KA, Pande M, Hong Y, Sima AA, Jagadish HV, Kretzler M, Feldman
Eva Feldman on 8/1/2012
Brain : a journal of neurology
Volume : Pages
134 : 3222 - 3235
Diabetic neuropathy is a common complication of diabetes. While multiple
pathways are implicated in the pathophysiology of diabetic neuropathy, there are
no specific treatments and no means to predict diabetic neuropathy onset or
progression. Here, we identify gene expression signatures related to diabetic
neuropathy and develop computational classification models of diabetic
neuropathy progression. Microarray experiments were performed on 50 samples of
human sural nerves collected during a 52-week clinical trial. A series of
bioinformatics analyses identified differentially expressed genes and their
networks and biological pathways potentially responsible for the progression of
diabetic neuropathy. We identified 532 differentially expressed genes between
patient samples with progressing or non-progressing diabetic neuropathy, and
found these were functionally enriched in pathways involving inflammatory
responses and lipid metabolism. A literature-derived co-citation network of the
differentially expressed genes revealed gene subnetworks centred on
apolipoprotein E, jun, leptin, serpin peptidase inhibitor E type 1 and
peroxisome proliferator-activated receptor gamma. The differentially expressed
genes were used to classify a test set of patients with regard to diabetic
neuropathy progression. Ridge regression models containing 14 differentially
expressed genes correctly classified the progression status of 92% of patients
(P < 0.001). To our knowledge, this is the first study to identify
transcriptional changes associated with diabetic neuropathy progression in human
sural nerve biopsies and describe their potential utility in classifying
diabetic neuropathy. Our results identifying the unique gene signature of
patients with progressive diabetic neuropathy will facilitate the development of
new mechanism-based diagnostics and therapies.
Investigators with authorship
University of Michigan
University of Michigan
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!